van der Waal I. Professional diagnostic delay in osteosarcomas of the jaws. Med Oral Patol Oral Cir Bucal. 2020 Nov 1;25 (6):e834-7.
doi:10.4317/medoral.24334
https://dx.doi.org/doi:10.4317/medoral.24334
1. Ottaviani G, Jaffe N. The Epidemiology of Osteosarcoma. Cancer Treat Res. 2009;152:3-13. |
PMid:20213383 |
2. van den Berg H, Schreuder WH, de Lange J. Osteosarcoma: a comparison of jaw versus nonjaw localizations and review of the literature. Sarcoma. 2013;2013:316123. |
PMid:23956680 PMCid:PMC3727198 |
3. Forteza G, Colmenero B, Lopez-Barea F. Osteogenic sarcoma of the maxilla and the mandible. Oral Surg Oral Med Oral Pathol. 1986;62:179-84. |
PMid:3462614 |
4. Garrington GE, Scofield HH, Cornyn J, Hooker SP. Osteosarcoma of the jaws. Analysis of 56 cases. Cancer. 1967;20:377-91. |
https://doi.org/10.1002/1097-0142(1967)20:3<377::AID-CNCR2820200306>3.0.CO;2-T |
PMid:5228026 |
5. Lee RJ, Arshi A, Schwartz HC, Christensen RE. Characteristics and prognostic factors of osteosarcoma of the jaws: a retrospective cohort study. JAMA Otolaryngol Head Neck Surg. 2015;141:470-7. |
PMid:25811167 |
6. Baumhoer D, Brunner P, Eppenberger-Castori S, Smida J, Nathrath M, Jundt G. Osteosarcomas of the jaws differ from their peripheral counterparts and require a distinct treatment approach. Experiences from the DOESAK Registry. Oral Oncol. 2014;50:147-53. |
PMid:24246156 |
7. Bouaoud J, Beinse G, Epaillard N, Amor-Sehlil M, Bidaul F, Brocheriou I, et al. Lack of efficacy of neoadjuvant chemotherapy in adult patients with maxillo-facial high-grade osteosarcomas: A French experience in two reference centers. Oral Oncol. Oral Oncol. 2019;95:79-86. |
PMid:31345398 |
8. Thariat J, Julieron M, Brouchet A, Italiano A, Schouman T, Marcy PY, et al. Osteosarcomas of the mandible: are they different from other tumor sites?. Crit Rev Oncol Hematol. 2012;82:280-95. |
PMid:21868246 |
9. Petrikowski CG, Pharoah MJ, Lee L, Grace MG. Radiographic differentiation of osteogenic sarcoma, osteomyelitis, and fibrous dysplasia of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;80:744-50. |
PMid:8680984 |
10. Dujardin F, Binh MB, Bouvier C, Gomez-Brouchet A, Larousserie F, Muret Ad, et al. MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone. Mod Pathol. 2011;24:624-37. |
PMid:21336260 |
11. Limbach AL, Lingen MW, McElherne J, Mashek H, Fitzpatrick C, Hyjek E, et al. The utility of MDM2 and CDK4 immunohistochemistry and MDM2 FISH in craniofacial osteosarcoma. Head Neck Pathol. 2020. |
PMid:32026294 |
12. Mayordomo E, Machado I, Giner F, Kresse SH, Myklebost O, Carda C, et al. A tissue microarray study of osteosarcoma: histopathologic and immunohistochemical validation of xenotransplanted tumors as preclinical models. Appl Immunohistochem Mol Morphol. 2010;18:453-61. |
PMid:20436344 |
13. Mardekian SK, Tuluc M. Malignant sarcomatous transformation of fibrous dysplasia. Head Neck Pathol. 2015;9:100-3. |
PMid:25159810 PMCid:PMC4382496 |
14. Tabatabaei SH , Jahanshahi G , Marvasti FD. Diagnostic Challenges of Low-Grade Central Osteosarcoma of Jaw: A Literature Review. J Dent (Shiraz). 2015;16:62-7. |
PMid:26046099 |
15. Wagner VP, Carlos R, Romañach MJ, Lopes MA, Speight PM, Vargas PA. Malignant transformation of craniomaxillofacial fibro-osseous lesions: A systematic review. J Oral Pathol Med. 2019;48:441-50. |
PMid:31062892 |
16. ElKordy MA, ElBaradie TS, ElSebai HI, Khairalla SM, Amin AA. Osteosarcoma of the jaw: Challenges in the diagnosis and treatment. Journal of the Egyptian National Cancer Institute. 2018;30:7-11. |
PMid:29490886 |
17. Werner M. Vermeidung von Pitfalls in der Knochentumordiagnostik aus der Sicht des Pathologen. Radiologe. 2016;56:536-42. |
PMid:27220770 |